Qiagen
(NYSE) QGEN
Qiagen Financials at a Glance
Market Cap
$8.02B
Revenue (TTM)
$2.10B
Net Income (TTM)
$402.17M
EPS (TTM)
$1.94
P/E Ratio
20.12
Dividend
$0.25
Beta (Volatility)
0.61 (Low)
Dividend
$0.25
Beta (Volatility)
0.61 (Low)
Price
$39.36
Volume
127,551
Open
$38.79
Price
$39.36
Volume
127,551
Open
$38.79
Previous Close
$39.36
Daily Range
$38.77 - $39.40
52-Week Range
$32.53 - $57.82
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.25
Beta (Volatility)
0.61 (Low)
Price
$39.36
Volume
127,551
Open
$38.79
Previous Close
$39.36
Daily Range
$38.77 - $39.40
52-Week Range
$32.53 - $57.82
Estimated Earnings Date
Aug 4, 2026
QGEN News
Will COVID-19 Derail New Drugs?
QGEN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Qiagen
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
5,654
CEO
Thierry L. Bernard
Website
www.qiagen.comHeadquarters
Venlo, LI 5912 PL, NL
QGEN Financials
Key Financial Metrics (TTM)
Gross Margin
61.58%
Operating Margin
24.85%
Net Income Margin
19.16%
Return on Equity
11.28%
Return on Capital
9.58%
Return on Assets
6.96%
Earnings Yield
4.97%
Dividend Yield
0.68%
Payout Ratio
13.49%
Stock Overview
Market Cap
$8.02B
Shares Outstanding
206.07M
Volume
127.55K
Avg. Volume
2.14M
Financials (TTM)
Gross Profit
$1.29B
Operating Income
$521.59M
EBITDA
$777.93M
Operating Cash Flow
$615.22M
Capital Expenditure
-$204.68M
Free Cash Flow
$410.54M
Cash & ST Invst.
$646.29M
Total Debt
$1.65B
Qiagen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$492.32M
+1.8%
Gross Profit
$309.60M
+0.3%
Gross Margin
62.89%
N/A
Market Cap
$8.02B
N/A
Market Cap/Employee
$1.40M
N/A
Employees
5,736
N/A
Net Income
$68.04M
-25.0%
EBITDA
$148.09M
-13.3%
Quarterly Fundamentals
Total Cash
$646.29M
-32.9%
Total Debt
$1.65B
+16.9%
Accounts Receivable
$411.32M
+20.7%
Inventory
$309.61M
+10.0%
Long Term Debt
$1.65B
+21.7%
Short Term Debt
$0.00
-100.0%
Return on Assets
6.96%
N/A
Return on Invested Capital
9.84%
N/A
Free Cash Flow
$53.75M
-43.9%
Operating Cash Flow
$100.63M
-28.0%